#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian epithelial cancer Ischaemic stroke Hyperchylomicronaemia Retinal artery occlusion Eosinophilic granulomatosis with polyangiitis Metastases to peritoneum Carcinoid syndrome Stargardt's disease Oesophageal atresia Niemann-Pick disease Follicular lymphoma stage III Neurotrophic keratopathy Alveolar proteinosis Prophylaxis against transplant rejection Palmar-plantar erythrodysaesthesia syndrome More trials…

    Learn about Rare Diseases

    Pleural mesothelioma malignant – Trials in Disease Combined immunodeficiency – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Glycogen storage disease type V – Treatment Richter’s syndrome – Basic Information Haemophilia – Diagnostics Friedreich’s ataxia Glomerulonephritis membranoproliferative – Life with Disease Von Willebrand’s disease Biotinidase deficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Efgartigimod Alfa Lazertinib SAROGLITAZAR HEMIMAGNESIUM [11C]Az14193391 Gefurulimab Sodium Valproate Tirzepatide Thymalfasin Pervi-Fus Disitamab Vedotin Altizide Golexanolone Tin816 Phleum Pratense Pollen Extract ADMILPARANT Tioguanine Vgl101 Alizapride Amphotericin B 20-HYDROXYECDYSONE More therapies…

    Learn about Your Condition

    Gastrointestinal disorder Polycystic liver disease Procedural headache HER2 protein overexpression Inborn error of metabolism Juvenile absence epilepsy Rectosigmoid cancer Hypogonadism male Ankylosing spondylitis Plasma cell myeloma Hereditary angioedema Cystic fibrosis Small intestine leiomyosarcoma Coronary artery bypass Burning mouth syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Oscar Lambret

Centre Oscar Lambret

3 Rue Frederic Combemale, Lille, 59000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of tovorafenib versus standard chemotherapy as first treatment for children with low-grade glioma with RAF gene changes

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant glioma
    Investigated Drugs:
    • Carboplatin
    • Tovorafenib
    • Vinblastine Sulfate
    Austria Belgium Czechia Denmark Finland France +10

  • Study on Atezolizumab for Patients with Locally Advanced Cervical Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Atezolizumab
    France

  • Study on Palbociclib and Drug Combination for Patients with Hormone Receptor Positive, HER2-Positive Metastatic Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Fulvestrant
    France Germany Italy Portugal Spain

  • Study on DF1001, Nivolumab, and Paclitaxel for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Df1001
    • Nivolumab
    • Paclitaxel Albumin-Bound
    Belgium Denmark France The Netherlands

  • Study of Ribociclib and Letrozole for Patients with High-Risk Estrogen Receptor-Positive, HER2-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Letrozole
    • Ribociclib
    France Spain

  • Study of EOS884448, Dostarlimab, and Inupadenant for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Dostarlimab
    • Human Igg1 Kappa Monoclonal Antibody Against Tigit
    • Inupadenant
    Belgium France Italy Spain

  • Study on Bevacizumab with Temozolomide and Irinotecan for Children with Relapsed or Refractory Neuroblastoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • Bevacizumab
    • Cyclophosphamide
    • Dinutuximab Beta
    Belgium Denmark France The Netherlands Spain

  • Study of Atezolizumab with High Dose Radiation vs. Radiation Alone for Patients with Oligometastatic Soft Tissue Sarcoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Atezolizumab
    France

  • Study on the Effectiveness of Hyperthermic Intraperitoneal Chemotherapy with Cisplatin and Sodium Thiosulfate for Ovarian Cancer Patients Undergoing Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Cisplatin
    • Sodium Thiosulfate
    Belgium France

  • Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Domvanalimab
    • Durvalumab
    • Infliximab
    Belgium France Germany Greece Hungary Italy +4
Previous Page
1 … 18 19 20 21 22 … 26
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!